These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 9210007)

  • 1. Ceftriaxone as a single agent in empirical therapy of unexplained fever in granulocytopenic children with solid tumors.
    Bartolozzi S; Clerico A; Properzi E; Minori A; Castello MA
    J Chemother; 1997 Jun; 9(3):227-31. PubMed ID: 9210007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategies for cost-containment: once-daily ceftriaxone plus amikacin as empiric therapy for febrile granulocytopenic children with cancer.
    Castagnola E; Lanino E; Giacchino R; Viscoli C; Dini G
    J Chemother; 1999 Feb; 11(1):54-60. PubMed ID: 10078782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of ceftriaxone and amikacin as single daily dose for the empirical management of febrile granulocytopenic children with cancer.
    Pession A; Prete A; Paolucci G
    Chemotherapy; 1997; 43(5):358-66. PubMed ID: 9309370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ceftriaxone monotherapy in the treatment of low-risk febrile neutropenia.
    Karthaus M; Wolf HH; Kämpfe D; Egerer G; Ritter J; Peters G; Südhoff T; Franke A; Heil G; Kullmann KH; Jürgens H
    Chemotherapy; 1998; 44(5):343-54. PubMed ID: 9732151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ceftriaxone alone or in Combination with Teicoplanin in the Management of Febrile Episodes in Neutropenic Children and Adolescents with Cancer on an Outpatient Base.
    Preis S; Jürgens H; Friedland C; Oudekotte-David AA; Thomas L; Göbel U
    Klin Padiatr; 1993; 205(4):295-9. PubMed ID: 8377450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized comparison of cefepime versus ceftazidime monotherapy for fever and neutropenia in children with solid tumors.
    Kebudi R; Görgün O; Ayan I; Gürler N; Akici F; Töreci K
    Med Pediatr Oncol; 2001 Apr; 36(4):434-41. PubMed ID: 11260566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monotherapy for empiric treatment of fever in granulocytopenic cancer patients.
    Wade JC; Johnson DE; Bustamante CI
    Am J Med; 1986 May; 80(5C):85-95. PubMed ID: 3521273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Empirical antimicrobial therapy with a single daily dose of ceftriaxone plus amikacin in febrile granulocytopenic patients: a pilot study.
    Meunier F; Van der Auwera P; Aoun M; Ibrahim S; Tulkens PM
    J Antimicrob Chemother; 1991 May; 27 Suppl C():129-39. PubMed ID: 1856142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Domiciliary treatment of febrile episodes in cancer patients: a prospective randomized trial comparing oral versus parenteral empirical antibiotic treatment.
    Minotti V; Gentile G; Bucaneve G; Iori AP; Micozzi A; Cavicchi F; Barbabietola G; Landonio G; Menichetti F; Martino P; Del Favero A
    Support Care Cancer; 1999 May; 7(3):134-9. PubMed ID: 10335931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Netilmicin plus ceftriaxone versus amikacin plus ceftriaxone in the treatment of infections in granulocytopenic patients.
    Krcméry V; Koza I; Mardiak J; Fuchsberger P; Spánik S; Trupl J; Horníková M; Kusenda Z; Sufliarsky J; Svec J
    Chemotherapy; 1992; 38(1):74-6. PubMed ID: 1618007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cefepime monotherapy is as effective as ceftriaxone plus amikacin in pediatric patients with cancer and high-risk febrile neutropenia in a randomized comparison.
    Pereira CA; Petrilli AS; Carlesse FA; Luisi FA; da Silva KV; de Martino Lee ML
    J Microbiol Immunol Infect; 2009 Apr; 42(2):141-7. PubMed ID: 19597646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fever and neutropenia in children with cancer: a therapeutic approach related to the underlying disease.
    Petrilli AS; Melaragno R; Barros KV; Silva AA; Kusano E; Ribeiro RC; Bianchi A
    Pediatr Infect Dis J; 1993 Nov; 12(11):916-21. PubMed ID: 8265281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cefepime monotherapy for the empirical treatment of fever in granulocytopenic cancer patients.
    Eggimann P; Glauser MP; Aoun M; Meunier F; Calandra T
    J Antimicrob Chemother; 1993 Nov; 32 Suppl B():151-63. PubMed ID: 8150759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Monotherapy with meropenem in febrile granulocytopenic patients].
    Sanz MA; Jarque I; Larrea L
    Enferm Infecc Microbiol Clin; 1997 Sep; 15 Suppl 1():69-72. PubMed ID: 9410073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of cefepime + netilmicin or ceftazidime + amikacin or meropenem monotherapy in febrile neutropenic children with malignancy in Turkey.
    Agaoglu L; Devecioglu O; Anak S; Karakas Z; Yalman N; Biner B; Eryilmaz E; Goksan B; Unuvar A; Agirbasli H; Can M; Bilgen H; Gedikoglu G
    J Chemother; 2001 Jun; 13(3):281-7. PubMed ID: 11450887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ceftriaxone plus amikacin in a single daily dose as empiric antibiotic therapy in granulocytopenic patients.
    Cudillo L; Masi M; Scimò MT; Tribalto M; Cantonetti M; Criscuolo D; Papa G
    J Chemother; 1989 Dec; 1(6):413-6. PubMed ID: 2614507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ceftriaxone in the outpatient treatment of cancer patients with fever and neutropenia.
    Karthaus M; Egerer G; Kullmann KH; Ritter J; Jürgens H
    Eur J Clin Microbiol Infect Dis; 1998 Jul; 17(7):501-4. PubMed ID: 9764553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Empirical antibiotic therapy in febrile neutropenic patients with single-daily dose amikacin plus ceftriaxone.
    Suwangool P; Aswapokee N; Sathapatayavongs B; Leelasuphasri S; Siritanaratkul N; Chuncharunee S; Chayakul P
    J Med Assoc Thai; 1993 Jun; 76(6):314-8. PubMed ID: 8083623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ceftriaxone vs. azlocillin and netilmicin in the treatment of febrile neutropenic children.
    Smith L; Will AM; Williams RF; Stevens RF
    J Infect; 1990 May; 20(3):201-6. PubMed ID: 2187928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vancomycin added to empirical combination antibiotic therapy for fever in granulocytopenic cancer patients. European Organization for Research and Treatment of Cancer (EORTC) International Antimicrobial Therapy Cooperative Group and the National Cancer Institute of Canada-Clinical Trials Group.
    J Infect Dis; 1991 May; 163(5):951-8. PubMed ID: 2019772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.